r. McCarthy was Executive Vice President for publicly-traded Verenium Corporation, a pioneering leader in the development and commercialization of cellulosic ethanol and specialty enzymes. At Verenium, McCarthy served as the chief architect of the company's growth from a small privately-held business into a publicly-traded leader in the industry through the successful merger and integration of Celunol and Diversa and the subsequent creation and execution of the industry's precedent-setting strategic corporate partnership with BP plc.
"We are thrilled to have John join us at this important stage of Qteros' development to lead and accelerate our technical, commercial and organizational growth plans," stated Steve Goldby, Qteros board member and Partner at Venrock Associates. "John's experience building pioneering companies in the biofuels industry such as Verenium, together with his proven track record of developing and managing complex strategic corporate partnerships, make him uniquely qualified to lead and position Qteros for significant growth."
"I am very pleased and excited to be joining Qteros at this critical stage of its development, and look forward to accelerating our technical and commercial plans as we focus on making our Q-Microbe™ platform a cellulosic ethanol industry standard," stated McCarthy.
"The broad alternative energy industry represents one of the most important and high-growth opportunities for this generation," McCarthy added. "I look forward to positioning Qteros and its partners as a leading technology solution to support the multi-billion gallon per year U.S. mandate and worldwide requirement for cellulosic ethanol production."
Mr. McCarthy's prior experience includes senior executive positions at Xanthus Pharmaceuticals, Synta Pharmaceuticals, Exact Sciences, Concentra Managed Care, and Morgan Stanley. Mr. McCarthy graduated with high honors
'/>"/>
SOURCE Qteros, Inc. Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction2.
N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation3.
Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction4.
Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"5.
NexGen Biofuels Ltd. (Nasdaq: NXGN) Announces Receipt of Nasdaq Delisting Determination6.
NexGen Biofuels Ltd. Announces Trading on OTC Bulletin Board7.
Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration8.
Performance Plants Establishes U.S. Biofuels Facility9.
NexGen Biofuels Ltd. Announces Plans to Replace its CFO With Local CFO10.
New Generation Biofuels Set to Join Russell Microcap Index11.
DOE JGI Director Eddy Rubin highlights the genomics of plant-based biofuels in the journal Nature